BASF Puts Mid-2027 Stamp on Agrochemicals IPO as Carve-Out Nears Completion

BASF progresses toward 2027 listing of Agricultural Solutions, with €20-30B valuation, as restructuring and buyback bolster shares.

The chemical giant's plan to float its crop-science division is shifting from blueprint to execution. Livio Tedeschi, the board member installed specifically to oversee the separation, confirmed that Agricultural Solutions has now been largely untangled from the parent group across North and South America and Europe, with the Asian operations slated to follow by the close of this year. That leaves the company aiming to have all the structural prerequisites in place by the middle of 2027.

Shareholders gave the green light to the carve-out back in April, with a listing tentatively penciled in for the second quarter of that year. Banking circles have floated a valuation of €20 billion to €30 billion for the unit — a figure that would make the standalone business worth roughly half of what the entire BASF group currently commands on the stock market.

More Than Just a Separation

The spin-off is only one strand of a broader restructuring. BASF wrapped up the sale of its Coatings division to Carlyle at the end of June, a deal that valued the business at €7.7 billion and left the parent with a 40 percent equity stake in the newly christened Surventis. The transaction generated pre-tax proceeds of around €5.8 billion.

Meanwhile, the agrochemical unit is being built up even as it is being broken away. A low-double-digit million-euro investment is flowing into a new Climate Center at Limburgerhof, designed to consolidate research and regulatory expertise. The group also completed its acquisition of AgBiTech from Paine Schwartz Partners at the end of March, following an agreement struck in January.

Tedeschi's appointment in May, alongside fellow new board member Mary Kurian, came as Michael Heinz retired — a reshuffle that put the IPO preparation squarely under dedicated leadership.

Operational Momentum Provides Cover

The restructuring effort is unfolding against a backdrop of improving fundamentals. Second-quarter revenue climbed by €2.4 billion to €17.2 billion, propelled by an 11.5 percent increase in prices and 7.3 percent volume growth. That performance prompted management to lift its full-year outlook, now targeting EBITDA before special items of €6.9 billion to €7.7 billion — a figure that came in well ahead of analyst consensus.

The share price has responded, gaining 3.0 percent since the guidance upgrade. The stock currently trades roughly 4.2 percent above its 50-day moving average, suggesting the market has yet to punish the group for the complexity of its transformation agenda.

Buyback Adds a Second Layer

Investors have also had a fresh capital-return program to digest. A new buyback of up to €1 billion got underway yesterday and is scheduled to run until the end of April 2027. It forms part of a broader €4 billion repurchase scheme announced in September 2024, under which BASF had already bought back shares worth approximately €1.5 billion between November 2025 and June 2026.

The company intends to cancel just over 31.6 million shares and reduce its share capital accordingly. Since the latest program began, the stock has added 1.4 percent, trading at €51.97 on Friday — still nearly six percent shy of its 52-week high of €55.05 set in April.

The Asia Question Looms Large

The most significant variable in the timetable is the pace of the Asian carve-out. Every other region has been largely separated, but Asia remains the least advanced piece of the puzzle. Any slippage there would put the entire 2027 schedule at risk, and the market's patience with the uncertainty over whether the final structure will be a full spin-off, a partial IPO, or a sale has yet to be tested.

External disruptions add another layer of fragility. CEO Markus Kamieth recently had to throttle some production due to low water levels on the Rhine — a constraint the company says had no material earnings impact, but one that illustrates how quickly outside factors can tighten an already stretched operational margin during a period of profound corporate change.

Analyst Divergence Reflects the Stakes

The investment community is split on how to read the story. DZ Bank raised its price target to €64 at the end of July while reaffirming a buy recommendation. Berenberg, by contrast, trimmed its target to €47 with a "Hold" rating in the same window — a reminder that the transformation narrative is far from universally embraced.

The next milestone for investors comes on October 28, when BASF hosts its third-quarter earnings call. That is when the market will look for fresh detail on the carve-out's progress and any adjustments to the guidance. For now, the path to a mid-2027 listing remains open — provided Asia delivers on schedule and the Rhine cooperates.